154 related articles for article (PubMed ID: 14967452)
1. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.
Chakravarti A; Dicker A; Mehta M
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):927-31. PubMed ID: 14967452
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
Karpel-Massler G; Schmidt U; Unterberg A; Halatsch ME
Mol Cancer Res; 2009 Jul; 7(7):1000-12. PubMed ID: 19584260
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
6. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.
Chakravarti A; Seiferheld W; Tu X; Wang H; Zhang HZ; Ang KK; Hammond E; Curran W; Mehta M
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):318-27. PubMed ID: 15890570
[TBL] [Abstract][Full Text] [Related]
8. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
Xu K; Shu HK
Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
[TBL] [Abstract][Full Text] [Related]
10. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
[TBL] [Abstract][Full Text] [Related]
11. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy.
Bianco R; Troiani T; Tortora G; Ciardiello F
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S159-71. PubMed ID: 16113092
[TBL] [Abstract][Full Text] [Related]
13. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
[TBL] [Abstract][Full Text] [Related]
14. Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis.
Steinbach JP; Eisenmann C; Klumpp A; Weller M
Biochem Biophys Res Commun; 2004 Aug; 321(3):524-30. PubMed ID: 15358139
[TBL] [Abstract][Full Text] [Related]
15. Signaling through the epidermal growth factor receptor during the development of malignancy.
Grandis JR; Sok JC
Pharmacol Ther; 2004 Apr; 102(1):37-46. PubMed ID: 15056497
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
Yang W; Wu G; Barth RF; Swindall MR; Bandyopadhyaya AK; Tjarks W; Tordoff K; Moeschberger M; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
Clin Cancer Res; 2008 Feb; 14(3):883-91. PubMed ID: 18245552
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Raben D; Helfrich B; Bunn PA
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
[TBL] [Abstract][Full Text] [Related]
19. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
Sonabend AM; Dana K; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
[TBL] [Abstract][Full Text] [Related]
20. Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway.
Toulany M; Dittmann K; Krüger M; Baumann M; Rodemann HP
Radiother Oncol; 2005 Aug; 76(2):143-50. PubMed ID: 16024124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]